Palo Alto Investors was founded by William Leland Edwards in 1989. The fund usually invests in companies with market capitalization less than $3 billion.
Keep Reading →
November 8 - Hedge Funds, News
William Leland Edwards' Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management.
Keep Reading →
March 2 - Hedge Funds, News
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States, with over $2 billion...
Keep Reading →
December 1 - Hedge Fund Analysis, Hedge Funds, News
William Leland Edwards' Palo Alto Investors is a reputable fund with a strong focus and in-depth knowledge of healthcare stocks, a sector that accounts for more than 80% of its...
Keep Reading →
July 17 - Hedge Fund Analysis, Hedge Funds, News
ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday's intraday trading to eventually close at 18% in the green at $72.48.
Keep Reading →
March 25 - Hedge Funds, Market Movers, News
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday.
Keep Reading →
December 29 - Hedge Funds, News
Jeremy Green's Redmile Group has also reduced its stake in Amicus Therapeutics, Inc.
Keep Reading →
October 9 - Hedge Funds, News
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD).
Keep Reading →
October 8 - Hedge Funds, News
Tim Mullen and his fund, Swift Run Capital Management, have sent a presentation to the management of VIRGINIA NATL BNK (OTCMKTS:VABK), in which they have outlined potential opportunities...
Keep Reading →
September 26 - Hedge Funds, News
Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since.
Keep Reading →
September 9 - Hedge Funds, News
Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S.
Keep Reading →
July 2 - Hedge Funds, News
Camber Capital Management, managed by Stephen Dubois, is bullish on Sequenom Inc. (NASDAQ:SQNM).
Keep Reading →
June 23 - Hedge Funds, News
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.
Keep Reading →
May 27 - Hedge Funds, News
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc.
Keep Reading →
March 7 - Hedge Funds, News
Samuel Isaly's Orbimed Advisors is one of the largest hedge funds focused almost entirely on the healthcare sector. In a recent intervention on CNBC, Mr.
Keep Reading →
March 6 - Hedge Funds, News
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Keep Reading →
January 16 - Hedge Funds, News
Kevin Kotler's Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed.
Keep Reading →
December 30 - Hedge Funds, News
William Leland Edwards' fund, Palo Alto Investors, just reported cutting down its entire position in nano-cap company Savient Pharmaceuticals Inc (OTCMKTS:SVNTQ).
Keep Reading →
November 12 - Hedge Funds, News
There are hedge fund recruiters who take great pride in helping people find a job in the hedge fund industry.
Keep Reading →
October 11 - Hedge Funds
Anacor Pharmaceuticals, Geoffrey Parker: In a recent Form 4 filing with the SEC, M.
Keep Reading →
October 7 - Insider Trading, News
Although there is a lot of hedge fund career advice out there, you need to focus on the details and tips that will put you in the best position to reach your goals.
Keep Reading →
October 3 - Hedge Funds
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, Inc...
Keep Reading →
September 9 - News
The top hedge funds: there are many reasons why you may be seeking information related to the best performing money managers. Maybe you want to find a job in this field.
Keep Reading →
July 25 - Hedge Funds
When it comes to hedge fund research, there used to be a time when getting your hands on the right information was a challenge.
Keep Reading →
July 25 - Hedge Funds
What are hedge funds? In today’s day and age, many people find themselves asking the question, and it's important to take a look at it closely.
Keep Reading →
July 25 - Hedge Funds
Since the end of 2Q, the very popular biopharma companies, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) and Vivus, Inc.
Keep Reading →
October 11 - Hedge Funds
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) made our list of terrible twenty stocks earlier this week.
Keep Reading →
September 25 - Stock Analysis
Martin Shkreli, MSMB Capital has succeeded in derailing the acquisition of Allos Therapeutics Inc. (ALTH) by AMAG Pharmaceuticals Inc. (AMAG).
Keep Reading →
October 21 - Hedge Funds
Martin Shkreli, CIO of MSMB Capital Management, took a 5.8% ownership interest in Amag Pharmaceuticals (AMAG) in a bid to prevent Amag merging with Allos Therapeutics (ALTH).
Keep Reading →
October 11 - News
Hedge Fund Resource Center 
